Bengaluru, India

Purushothama Narasiyappa

This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Shilpa Medicare Limited, Shilpa Pharma Lifesciences Limited. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Purushothama Narasiyappa: Innovator in Injectable Pharmaceutical Compositions

Introduction

Purushothama Narasiyappa is an accomplished inventor based in Bengaluru, India. He is currently associated with Shilpa Medicare Limited, where he focuses on developing innovative pharmaceutical solutions. Despite having no granted patents to his name, his contributions to the field of injectable compositions are noteworthy.

Latest Patent Applications

Purushothama Narasiyappa has been involved in several significant patent applications. One of his latest applications is for "Injectable Compositions of Ursodeoxycholic Acid." This invention is directed towards an injectable pharmaceutical composition that includes ursodeoxycholic acid and sulfobutylether-β-cyclodextrin. The compositions demonstrate unexpected solubility and stability, allowing for therapeutic dosages to be administered without the need for high amounts of strong bases.

Another notable application is for "Controlled Release Injectable Ondansetron Formulations." This invention relates to a controlled release injectable formulation that comprises ondansetron or its pharmaceutically acceptable salts, derivatives, or metabolites. The formulation is designed to release ondansetron over a period of at least two days from the date of administration, enhancing its therapeutic efficacy.

Conclusion

Purushothama Narasiyappa is a dedicated inventor making strides in the pharmaceutical industry through his innovative applications. His work in injectable compositions showcases his commitment to advancing medical treatments and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…